Tagungen und Workshops zum Thema Pharmakologie und Arzneimittelentwicklung

Conference-Service.com stellt der Öffentlichkeit ein Kalendarium wichtiger Konferenzen, Symposien und sonstiger Tagungen im wissenschaftlich-technischen Bereich zur Verfügung. Obwohl das Verzeichnis mit großer Sorgfalt zusammengestellt und ständig aktualisiert wird, weisen wir auf die Möglichkeit von Fehlern ausdrücklich hin. Bitte vergewissern Sie sich immer beim Veranstalter, bevor Sie über die Teilnahme oder Nichtteilnahme an einer Konferenz entscheiden.

Organisatoren können kostenlos ihre Konferenzankündigungen veröffentlichen.

ALLE LÄNDER

1.
 
ADC EU — World ADC Berlin 2016
ID
762647
Termin
08. Feb 2016 - 10. Feb 2016
Ort
Berlin, Deutschland
Zusammenfassung
Now in its 6th year, World ADC Berlin is the industry’s definitive conference for sharing new antibody drug conjugate insights and data. Thought leaders from Pfizer, MedImmune, Genentech, Merck and 40+ others will divulge unpublished, never seen before ADC drug research. Over 3 days, 60+ sessions will cover every aspect of ADC drug development from discovery, preclinical, clinical and marketisation giving you an unparalleled opportunity to gain insights and advance your ADC program. Make sure you keep pace with the latest advancements and develop the next generation of therapeutically successful ADCs.
Kontakt
Charlotte Parnaby;     Tel.: [+44 (0)20 3141 8700];     Email: adc@hansonwade.com
Themen
adc, antibody, drug, conjugate, conjugates, antibody drug conjugates
Verwandte Fachgebiete
2.
 
Targeted Drug Delivery
ID
749204
Termin
11. Feb 2016 - 12. Feb 2016
Ort
Basel, Schweiz
Zusammenfassung
2-day masterclass will provide a detailed overview of the newest strategies and achievements in drug delivery and targeting, with particular attention paid to the use of nanoparticles, macromolecules, nucleic acids and small molecule conjugates.
Kontakt
Andrea Weber;     Email: andrea.weber@flemingeurope.com
Themen
Tagreted drug delivery, Targeting strategies, Drug Development, Nanoparticles, Antibody-Drug conjugates, ADCs, Vaccine delivery, Nanotheranostics, Drug delivery devices, Bio-instrumentation, Nanopharmaceuticals, Magic bullet therapy, Cancer drug targeting
3.
 
RNA 2016 — RNA Therapeutics
ID
748080
Termin
15. Feb 2016 - 16. Feb 2016
Ort
London, Großbritannien
Zusammenfassung
With a focus on messenger RNA-based therapeutics and anti-sense oligonucleotide-based drugs, the 2016 agenda will tackle the challenge of transporting RNA to target sites outside the liver and optimise bioavailability and kinetics.
Kontakt
Teri Arri;     Tel.: [+44 (0)20 7827 6162];     Email: tarri@smi-online.co.uk
Themen
RNAi, rna therapeutics, delivery systems, drug safety, animal models, cell culture, cell, mrna, clinical trials, immune response, liver, oligonucleotide, ligand, receptor, gene expression, in vitro, in vivo, drug safety, nanotechnology, nanoparticles, cell dianostics, hepatocytes, antibody conjugate, pharmacokinetics, gene silencing, protein, formulation, cgmp, endocytosis, aptamer
Verwandte Fachgebiete
4.
 
icddt — 7th International Conference on Drug Discovery and Therapy
ID
723318
Termin
15. Feb 2016 - 18. Feb 2016
Ort
Dubai, Vereinigte Arabische Emirate
Zusammenfassung
The 7th ICDDT will highlight cutting-edge advances in all major disciplines of Drug Discovery and Drug Therapy. This four-day event will feature recent findings from leading industrial, clinical and academic experts in the field, in the form of lectures and posters. The 7th ICDDT will be unique in promoting the translational nature of modern biomedical and pharmaceutical research, with both scientists and clinicians associated with either patient care or with drug discovery research. A number of Nobel Laureates will deliver keynote lectures at the conference. It will bring together leading clinicians, medicinal chemists, pharmacologists, biotechnologists, and other allied professionals to discuss and present the latest important developments in drug discovery and therapeutics.
Kontakt
Qasit;     Tel.: [(+971-6-5575783)];     Email: marketing@icddt.com
5.
 
Project management tools to improve productivity and compliance in Analytical laboratories
ID
789770
Termin
18. Feb 2016 - 19. Feb 2016
Ort
San Francisco, Vereinigte Staaten
Zusammenfassung
The pressure has been mounting in the pharma and biopharma industries in recent years to do more with less. Analytical laboratories are no exception to this trend. Work piles up while personnel have been cut or remain stagnant. Accelerated timelines further strain resources. Constant firefighting and band-aiding results in errors as well as compliance violations. It can be argued that the cost of non-compliance is more than that of compliance.Note: Use coupon code NB5SQH8N and get 10% off on registration.
Kontakt
Referral;     Tel.: [8887172436];     Email: referral@complianceonline.com
Themen
project management tools, analytical testing laboratories, Analytical laboratories
6.
 
Validation, Verification and Transfer of Analytical Methods (Understanding and implementing guidelines from FDA/EMA, USP and ICH)
ID
789813
Termin
18. Feb 2016 - 19. Feb 2016
Ort
San Francisco, Vereinigte Staaten
Zusammenfassung
Analytical methods and procedures should be validated to ensure reliability, consistency and accuracy of analytical data. Compendial methods should be verified to demonstrate the suitability of laboratories to successfully run the method and when methods are transferred between laboratories successful transfer should be demonstrated through testing. In case a laboratory wants to use an alternative method instead of a compendial method, equivalency of the alternative method to the compendial method should be demonstrated.Note:Use coupon code NB5SQH8N and get 10% off on registration.
Kontakt
Referral;     Tel.: [8887172436];     Email: referral@complianceonline.com
Themen
Laboratory compliance, Analytical methods, data, procedures, compendial methods, Method validation and transfer, equivalency testing
7.
 
ADPHaC2016 — 1st Abu Dhabi Pharmacy Conference
ID
784185
Termin
19. Feb 2016 - 21. Feb 2016
Ort
Dubai, Vereinigte Arabische Emirate
Zusammenfassung
A unique conference bringing together some of the most recognized names in healthcare & pharmacy practice, providing you with the opportunity to advance your practice, gain new knowledge, develop new ideas for your organizations as well network with your peers and experts in the field. Recognizing that learning is best accomplished through an engaging and interactive setting, ADPhaC will also feature several workshops and networking sessions which will give you the chance to meet and interact with field experts and delegates in a casual setting.
Kontakt
Basil Kadara;     Tel.: [97144532975];     Email: contact@diaedu.com
Themen
Pharmacy, Medicine, Pharmacology
8.
 
LDN 2016 — The LDN 2016 AIIC Conference
ID
725270
Termin
19. Feb 2016 - 21. Feb 2016
Ort
Orlando, Vereinigte Staaten
Zusammenfassung
The LDN AIIC 2016 Conference is produced by the LDN Research Trust, a non-profit, Registered Charity dedicated to raising awareness as well as funding research and clinical trials of LDN as a treatment for Crohn's Disease, Colitis, Autism, IBS, Lupus, Fibromyalgia, Rheumatoid, Arthritis, Chronic Pain and other auto-immune diseases. The central role of the conference is to review, compare and contrast the most recent LDN-related data and treatments. It also offers compelling examples, experiences and case studies from many of the world’s leading experts, practitioners and patients who are using LDN to achieve positive, and in many cases, life-changing results.
Kontakt
Jim Warner;     Tel.: [+1 770-663-8803];     Email: jim.warner@ldn2016.com
Themen
LDN, MS, Chrohns, Fibromyalgia, Chronic Pain, Autism, Colitis, ME/CFS
Verwandte Fachgebiete
9.
 
G Protein-Coupled Receptors: Structure, Signaling and Drug Discovery
ID
740019
Termin
21. Feb 2016 - 25. Feb 2016
Ort
Keystone, Vereinigte Staaten
Zusammenfassung
The field of G protein-coupled receptors has recently seen major advances in high-resolution structure determination, as well as the validation of novel paradigms of drug action, such as allosteric modulation and biased agonism, as likely universal mechanisms. These studies are opening new insights into the diversity of this receptor superfamily, teaching us new lessons in receptor functionality and hinting at novel avenues to investigate. At the same time, we are seeing exciting discoveries in GPCR intracellular signaling and physiology. The timing is right to bring together researchers in these different areas. This Keystone Symposia meeting will focus on the interplay between these discoveries and how they are being used to advance GPCR-based research toward improved clinical outcomes. 
Verwandte Fachgebiete
10.
 
Effectively Addressing and Remediating FDA's Form 483 Findings, Warning Letters and Consent Decree Compliance Issues
ID
789790
Termin
22. Feb 2016 - 23. Feb 2016
Ort
Orlando, Vereinigte Staaten
Zusammenfassung
This seminar will guide the attendee in effectively handling, addressing and remediating FDA's and other related compliance issues associated such as FDA's Form 483, Warning Letter and Consent Decree Compliance Findings. An effective handling and resolution of Compliance issues will prevent further disciplinary actions such as an FDA's Warning Letter or a formal Consent Decree which ends with a costly impact, fines and possible injunctions by the FDA.Note: Use coupon code NB5SQH8N and get 10% off on registration.
Kontakt
Referral;     Tel.: [8887172436];     Email: referral@complianceonline.com
Themen
FDA Form 483 Warning Letters, FDA Consent Decree, FDA injunction, Code of Federal Regulations, FDA Form 483 Seminar
11.
 
Africa Pharmaceutical Summit
ID
725674
Termin
24. Feb 2016 - 25. Feb 2016
Ort
Nairobi, Kenia
Zusammenfassung
In its 3rd year, the Africa Pharmaceutical Summit (APS) is now established as the most strategic industry event in the region that brings together all major stakeholders – industry leaders, policy-makers, regulators, academics, investors, scientists and patient representatives, to tackle the most pressing issues the industry is facing and enhance multi-stakeholder cooperation on issues relating to pharmaceutical sector development in this fast growing region of the world. Building a competitive agenda can have a major influence on investment decisions, and is an ideal platform for the pharmaceutical industry to invest, contributing to the health of everyone living in Africa, and to the local economies. A sophisticated partnership and regular dialogue between industry and government adds value to this agenda. A UNIQUE PLATFORM AND IDEAL MEETING PLACE, IN A FAST GROWING REGION OF THE WORLD, FOR POLICY MAKERS, SENIOR PHARMACEUTICAL AND HEALTHCARE INDUSTRY EXECUTIVES, INVESTORS AND STAKEHOLDERS
12.
 
Ubiquitin Research & Drug Discovery Conference
ID
744985
Termin
24. Feb 2016 - 25. Feb 2016
Ort
San Diego, Vereinigte Staaten
Zusammenfassung
Recent breakthroughs in research, such as the phosphorylation of ubiquitin, have exciting implications for drug discovery. This meeting seeks to create a forum for scientists to discuss advances in structural insights, novel drug targets, and other hot topics in ubiquitin-pathway research. Attend this event not only for updates on the latest scientific research, but also for networking sessions between colleagues from both industry and academia in order to get the most comprehensive exchange of ideas. 
13.
 
Enzymes in Drug Discovery Summit
ID
744895
Termin
24. Feb 2016 - 26. Feb 2016
Ort
San Diego, Vereinigte Staaten
Zusammenfassung
The summit will bring together an exciting balance of industry and academia, so that delegates have the unique opportunity to network with colleagues from different sectors and gain fresh perspective on the various research happening.
14.
 
11th Annual Biomarkers Congress
ID
743494
Termin
25. Feb 2016 - 26. Feb 2016
Ort
Manchester, Großbritannien
Zusammenfassung
Our renowned biomarkers congress showcases world-class speakers discussing novel developments in pre-clinical biomarker research, personalised medicine, clinical research and diagnostics.
Kontakt
Danielle Dalby;     Tel.: [+44 (0)1865 248455];     Email: d.dalby@oxfordglobal.co.uk
15.
 
Patient Adherence and Compliance Masterclass
ID
749669
Termin
25. Feb 2016 - 26. Feb 2016
Ort
Amsterdam, Niederlande
Zusammenfassung
The pharmaceutical industry is undergoing changes, and is shifting towards patient centricity. innovative outlooks and patient insights bring a new weapon to the battle against established challenges. non-adherence increases medical costs, creates waste in medical spending, multiplies the number of hospitalizations and threatens lives. The issue touches all stakeholders involved in healthcare: from the pharmaceutical companies to doctors to the patients themselves. Therefore, effective improvement is possible only through the cooperation of multiple stakeholders. improve stakeholder collaboration, build lasting relationships, learn about the challenges of others and improve adherence for the benefit of all. Whether you are an industry representative, a medical doctor, a health insurance representative or a member of a patient organization, the Patient adherence and compliance masterclass is the perfect opportunity to join forces with other stakeholders and make progress in improving adherence.
Kontakt
Andrea Weber;     Tel.: [+421257272145];     Email: andrea.weber@flemingeurope.com
Themen
Patient Compliance, Patient Value, Patient Engagement, patient solutions
16.
 
Epigenetic Enzymes in Drug Discovery Summit
ID
744916
Termin
25. Feb 2016 - 26. Feb 2016
Ort
San Diego, Vereinigte Staaten
Zusammenfassung
Epigenetic Enzymes in Drug Discovery Summit will bring together an exciting balance of industry and academia, so that delegates have the unique opportunity to network with colleagues from different sectors and gain fresh perspective on the various research happening.  
17.
 
Protease Inhibitors in Drug Discovery Conference
ID
744977
Termin
25. Feb 2016 - 26. Feb 2016
Ort
San Diego, Vereinigte Staaten
Zusammenfassung
Though protease inhibitors hold great therapeutic promise in areas such as inflammation, cardiovascular diseases, and cancer, researchers in the field are still overcoming the challenge of specificity for drug design. This meeting will provide a forum for scientists from both industry and academia to share recent advances in protease inhibitor research, from biological functions to translational aspects for drug discovery. Speakers will cover topics such as regulation of proteases by exosites, deubiquitinating enzymes, membrane-associated proteolysis, and many more. In addition to cutting-edge scientific presentations, attendees will be able to form new connections during dedicated networking sessions.
18.
 
Seminar on HIPAA 2016 - Upcoming Changes - Revenue Growth and HIPAA Dangers - Market Vigorously and Comply with HIPAA at New Orleans, LA
ID
774014
Termin
25. Feb 2016 - 26. Feb 2016
Ort
New Orleans, Vereinigte Staaten
Zusammenfassung
Paul Hales, with a team of expert advisors and practical field testers, have created a method of making all HIPAA regulations accessible to the everyday person, explained in plain language with exact citations to each regulation for the benefit of the organizations' legal counsel who may not be experienced in HIPAA.
Kontakt
Event Manager;     Tel.: [0800 4479407];     Email: support@globalcompliancepanel.com
Themen
HIPAA 2016, HIPAA Compliance Program, HIPAA enforcement, HIPAA's Privacy, Breach, and Security Rules, HIPAA Risk Analysis
19.
 
Data Management and Statistical Issues with Clinical Trials
ID
782548
Termin
25. Feb 2016 - 26. Feb 2016
Ort
Miami, Florida, Vereinigte Staaten
Zusammenfassung
This two-day workshop will be conducted by an industry expert who has wealth of experience managing data in clinical trials. After attending this workshop, you can be rest assured that you will be much better equipped in managing data and statistical issues in a compliant way. The tips that the instructor will share during the course of the training program will be invaluable, regardless of where you are in your career.
Kontakt
Peter Brown;     Tel.: [+1 410-501-5777];     Email: pbrown@fdamap.com
Themen
clinical trial, clinical data management, drug development, clinical trial management
20.
 
Medical Device Risk Management A to Z - Best Practices for Effectiveness and Efficiency
ID
789899
Termin
25. Feb 2016 - 26. Feb 2016
Ort
San Francisco, Vereinigte Staaten
Zusammenfassung
The course is designed for Medical Products Manufacturers. The course will be taught for Medical Devices and Combination Products, but will also be of benefit to Pharmaceutical Manufacturers.Note:Use coupon code NB5SQH8N and get 10% off on registration.
Kontakt
Referral;     Tel.: [8887172436];     Email: referral@complianceonline.com
Themen
ISO 14971 Training, medical device risk management training, medical device risk management best practices
21.
 
Designing and Sustaining New and Existing Product Stability Testing Program
ID
789843
Termin
25. Feb 2016 - 26. Feb 2016
Ort
Orlando, Vereinigte Staaten
Zusammenfassung
New or existing modified drug Stability Testing Program's regulations/requirements stipulated by the FDA, 21 CFR or other regulations may sometimes creating an overwhelming situation based on the type of product that is being manufactured. Hence, some manufacturers of new drug products have made inadvertent mistakes in the design of their new drug stability testing program.Note:Use coupon code NB5SQH8N and get 10% off on registration.
Kontakt
Referral;     Tel.: [8887172436];     Email: referral@complianceonline.com
Themen
FDA's Drug Stability Testing Program, NDA submission, 21CFR 514.1(b)(5)(x) expectations, Analytical Testing Considerations
22.
 
How to Prepare for an FDA Meeting: Making the Most of Pre-IND/IDE, pre-NDA and Other Critical Meetings
ID
789886
Termin
25. Feb 2016 - 26. Feb 2016
Ort
Washington, Vereinigte Staaten
Zusammenfassung
Despite a few guidance documents to help sponsors prepare for meetings with the FDA, it is a challenge to understand the most efficient and productive ways to strategize, prepare, conduct, and follow-up for these meetings. There are many misconceptions about the expectations from these meetings both for the sponsor and the FDA, and hence many sponsors fail to get the most benefit from them. Over the years, the FDA has also revised processes and practices for meeting with sponsors.Note:Use coupon code NB5SQH8N and get 10% off on registration.
Kontakt
Referral;     Tel.: [8887172436];     Email: referral@complianceonline.com
Themen
FDA meeting requirements, FDA meetings planning, FDA meeting stages, FDA meeting guidance, meetings with FDA
23.
 
Statistical Analysis for Process and Product Development
ID
789841
Termin
25. Feb 2016 - 26. Feb 2016
Ort
San Francisco, Vereinigte Staaten
Zusammenfassung
This course is designed to help scientists and engineers apply statistical methods used assist decision making in process and product development. Variability must be considered when utilizing data to arrive at conclusions. This course will cover Basic Statistics and Graphical Methods used to summarize data.
Kontakt
Referral;     Tel.: [8887172436];     Email: referral@complianceonline.com
Themen
Statistical analysis for product development trainings, statistical methods, product development, statistics and graphical methods
Verwandte Fachgebiete
24.
 
6th Ubiquitin Research & Drug Discovery Conference
ID
765691
Termin
29. Feb 2016 - 01. Mär 2016
Ort
San Diego, Vereinigte Staaten
Zusammenfassung
We are pleased to invite you to GTCbio's 6th Ubiquitin Research & Drug Discovery Conference, which will take place February 29 - March 1, 2016 in San Diego, CA. This conference will provide a forum for researchers from industry and academia to learn about recent advances in basic science and drugs that target the ubiquitin/proteasome system. Hot topics such as autophagy in cancer, developments with deubiquitinating enzymes, and novel drug targets in the ubiquitin system will be covered.
Kontakt
Kristen Starkey;     Tel.: [16262566405];     Email: infogtcbio@gtcbio.com
25.
 
11th Protein Kinases in Drug Discovery Conference
ID
765778
Termin
29. Feb 2016 - 01. Mär 2016
Ort
San Diego, Vereinigte Staaten
Zusammenfassung
We invite you to attend the 11th Protein Kinases in Drug Discovery Conference, which will take place February 29 - March 1, 2016 in San Diego, CA.
Kontakt
Kristen Starkey;     Tel.: [16262566405];     Email: infogtcbio@gtcbio.com
26.
 
Enzymes in Drug Discovery Summit
ID
760811
Termin
29. Feb 2016 - 02. Mär 2016
Ort
San Diego, Vereinigte Staaten
Zusammenfassung
We are excited to announce the Enzymes in Drug Discovery Summit, which will take place February 29 - March 2, 2016 in San Diego, CA.

Enzymes have proven to be an important group of drug targets in diseases, and enzyme inhibitors have been among the most successful of drugs. Join us as we discuss ways to overcome drug resistance to these inhibitors, and discuss breakthroughs in targeting historically undruggable enzymes.

Kontakt
Jessi Huang;     Tel.: [16262566405];     Email: jessi.huang@gtcbio.com
Themen
Enzymes in Drug Discovery
27.
 
Pharmacodynamics, Biomarkers and Personalised Therapy
ID
714629
Termin
29. Feb 2016 - 04. Mär 2016
Ort
Oxford, Großbritannien
Zusammenfassung
The Pharmacodynamics, Biomarkers and Personalised Therapy course is a one-week module of the MSc in Experimental Therapeutics. Offered by the Department of Oncology and the Department for Continuing Education’s CPD Centre, the week will be led by Dr Elaine Johnstone, Senior Research Fellow at the University of Oxford, and will feature face-to-face lectures and tutorials from some of Oxford's leading clinicians and scientists, as well as a practical visit to one of Oxford's research laboratories.The module can be taken as a stand-alone short course. It includes group work, discussions, guest lectures, and interaction and feedback with tutors and lecturers.
Kontakt
Course Administrator;     Tel.: [01865 286955];     Email: expther@conted.ox.ac.uk
28.
 
Pharmacokinetics for Pharmaceutical Scientists Course
ID
725754
Termin
29. Feb 2016 - 04. Mär 2016
Ort
San Francisco, Vereinigte Staaten
29.
 
2nd Protease Inhibitors in Drug Discovery Conference
ID
765819
Termin
01. Mär 2016 - 02. Mär 2016
Ort
San Diego, Vereinigte Staaten
Zusammenfassung
We are excited to announce the 2nd Protease Inhibitors in Drug Discovery Conference, which will take place March 1 - 2, 2016 in San Diego, CA.
Kontakt
Kristen Starkey;     Tel.: [16262566405];     Email: infogtcbio@gtcbio.com
30.
 
Epigenetic Enzymes in Drug Discovery Conference
ID
765829
Termin
01. Mär 2016 - 02. Mär 2016
Ort
San Diego, Vereinigte Staaten
Zusammenfassung
We invite you to attend the Epigenetic Enzymes in Drug Discovery Conference, which will take place March 1 - 2, 2016 in San Diego, CA.
Kontakt
Kristen Starkey;     Tel.: [16262566405];     Email: infogtcbio@gtcbio.com
31.
 
Manufacturing and Marketing OTC Drugs in Compliance with FDA Regulations (Updated to address recent Homeopathic Drug announcements by FDA & FTC)
ID
789873
Termin
01. Mär 2016 - 02. Mär 2016
Ort
Tampa, Vereinigte Staaten
Zusammenfassung
This interactive one and a half day seminar is intended to help companies understand the legal definitions of cosmetics, drugs, dietary supplements and why certain labeling statements for non-drug products may cause the agency to consider them new drugs without FDA approval.Note: Use coupon code NB5SQH8N and get 10% off on registration.
Kontakt
Referral;     Tel.: [8887172436];     Email: referral@complianceonline.com
Themen
Cosmeceuticals, dietary supplements, cosmetics, homeopathic OTCs, FDA regulations
32.
 
Quality Control Laboratory Compliance - cGMPs and GLPs
ID
789861
Termin
03. Mär 2016 - 04. Mär 2016
Ort
Tampa, Vereinigte Staaten
Zusammenfassung
FDA inspection and oversight of quality control (QC) laboratories are essential elements of the agency’s evaluation of the compliance status of regulated companies representing multiple industries - pharmaceuticals, biologics, medical devices, as well as foods and cosmetics - as well as the contract QC laboratories which service these industries. Lack of compliance can result in severe regulatory actions, criminal liability, fines, and the inability to obtain product approvals.Note:Use coupon code NB5SQH8N and get 10% off on registration.
Kontakt
Referral;     Tel.: [8887172436];     Email: referral@complianceonline.com
Themen
Quality Control Lab regulations, QC Lab regulations, FDA QC Lab requirements, FDA lab regulations, Good Laboratory Practices
33.
 
XVII CONGRESO INTERNACIONAL DE LA ORGANIZACIÓN DE FARMACÉUTICOS IBEROLATINOAMERICANOS y V CONGRESO NACIONAL DE USO RACIONAL DE MEDICAMENTOS
ID
745803
Termin
03. Mär 2016 - 05. Mär 2016
Ort
PUERTO VALLARTA, Mexiko
Zusammenfassung
Evento dirigido a profesionales y estudiantes del �rea de la salud. Tiene como objetivo promover una cultura para el Uso Racional de Medicamentos,  para lo cual hemos reunido especialistas en el �rea de nivel mundial, que  abordar�n temas como seguimiento de la farmacoterapia, mejora en la seguridad del paciente apoy�ndose en la farmacovigilancia, junto con cambios en la atenci�n farmac�utica tanto comunitaria en el primer nivel, como en la especializada en hospitales e instituciones sanitarias. Incluye adem�s, temas orientados con el uso de opioides y f�rmacos en el embarazo y la lactancia.  
34.
 
Antibodies as Drugs
ID
740148
Termin
06. Mär 2016 - 10. Mär 2016
Ort
Whistler, Kanada
Zusammenfassung
Monoclonal antibodies have had a pronounced impact in medicine and biology, with a broad array of approved agents that are used for the diagnosis, treatment and characterization of cancers, immunological disorders, and infectious diseases. Because of their exquisite target specificities, together with their favorable pharmacologic properties, antibodies are destined to have even increased clinical impact, particularly in diseases that are understood at the molecular level. This Keystone Symposia meeting will focus attention on many of the key advances in antibody-based technologies as well as on where the field is heading. Some of the critical topics to be covered include: 1) Antibody structure and function; 2) Engineered antibodies and antibody-like molecules for improved efficacy; 3) Antibody pharmacologic properties and biologic distribution; 4) Antibody-based therapies for cancer and infectious diseases; 5) Targeting costimulatory pathways and immunological checkpoints; 6) Antibodies as carriers of drugs, cytokines, radioisotopes and imaging agents; 7) Antibody mimetics; 8) Clinical advancements and challenges. This meeting has become an established forum that attracts both new investigators and leaders in the field, coming from academia, industry and research institutes around the globe. The goals of the meeting will be to address the critical issues facing the broad field of antibody-based therapeutics, provide an overview of recent advances and bring together interdisciplinary groups for the generation of new ideas and promising areas of investigation. This meeting is being held jointly with  Cancer Vaccines: Targeting Cancer Genes for Immunotherapy.
Verwandte Fachgebiete
35.
 
CDISC Mapping and Strategies Implemented
ID
789860
Termin
07. Mär 2016 - 08. Mär 2016
Ort
Philadelphia, Vereinigte Staaten
Zusammenfassung
CDISC requirements to create SDTMs and ADaMs are not easy to understand or apply. There are many rules and standards that must be mastered and maintained across global studies. Pharmaceutical companies and CROs supporting global studies have a need to apply proven methods that reduce confusion and improve documentation. With new members joining the study team, there should be a system to help standardize and automate the FDA submission process.Note: Use coupon code NB5SQH8N and get 10% off on registration.
Kontakt
Referral;     Tel.: [8887172436];     Email: referral@complianceonline.com
Themen
CDISC mapping training, OpenCDISC, CDISC datasets, SDTM, ODM, SDM models, ADAM metadata excel file
36.
 
World ADC Berlin
ID
771806
Termin
08. Mär 2016 - 10. Mär 2016
Ort
Berlin, Deutschland
Zusammenfassung
Learn from the industry thought leaders on developing payloads with different mechanisms of action, effectively translating ADCs into the clinic and advancing clinical scale manufacturing.
Kontakt
Jenny Barlow;     Tel.: [44 (0)203 141 8700];     Email: info@hansonwade.com
37.
 
BMCS Mastering MedChem II: 2nd RSC-BMCS symposium on mastering medicinal chemistry
ID
740160
Beginn
09. Mär 2016
Ort
Huddersfield, Großbritannien
Zusammenfassung
This meeting is aimed at all those who wish to become better drug hunters and heed warnings from the past.
38.
 
2ACPC2016 — 2nd Anti-Counterfeiting Pharma Conference 2016
ID
782901
Termin
09. Mär 2016 - 10. Mär 2016
Ort
London, Großbritannien
Zusammenfassung
We welcome you to be a part of Recunnect’s 2nd Anti-Counterfeiting Pharma 2016 Conference showcasing the anti-counterfeiting strategies for a better informed decision making. The aim is to foster discussion on how to tackle counterfeiting and improve patient safety. Gain the best insight into the most pressing challenges through practical advice on streamlining procedures and practices in the industry.
Kontakt
Sarika Sareen;     Tel.: [442071129183];     Email: info@recunnect.com
Themen
Anti-Counterfeiting pharmaceuticals Conferences medicine health drugs drugs safety
39.
 
5th RSC / SCI symposium on Ion Channels as Therapeutic Targets
ID
740269
Termin
14. Mär 2016 - 15. Mär 2016
Ort
Cambridge, Großbritannien
Zusammenfassung
Ion Channels are important targets for therapeutic intervention due to their extensive roles in human physiology and the pathophysiology of disease. Many successful drugs targeting ion channels have been discovered for diseases such as hypertension, epilepsy and chronic neuropathic pain, but few were rational designed until recently.
40.
 
New Perspectives for Generic Pharmaceutical Industry
ID
766312
Termin
15. Mär 2016 - 16. Mär 2016
Ort
München, Deutschland
Zusammenfassung
Participants will systematically evaluate and develop an understanding of the current situation in the generic pharma industry and learn about new strategies and future challenges.
Kontakt
Andrea Weber;     Tel.: [+421 257 272 155];     Email: andrea.weber@fleming.events
Themen
Post patent cliff, Generic industry, Super generics, Innovation, Diferentiation, Sustainable product portfolio, Future of Generics, Pricing of Generics, Regulatory differences in EU
41.
 
Immune Checkpoint Inhibitors 2016
ID
771730
Termin
15. Mär 2016 - 17. Mär 2016
Ort
Boston, Vereinigte Staaten
Zusammenfassung
As the frenzy of preclinical and clinical programs continues, it is critical to take a step back and work out what is working and what is not. At this year’s ICI Boston we are gathering the field’s experts to review the latest research and clinical success of checkpoint modulators. With insights and fresh data from early validation through to clinical strategy we’ve curated the most valuable and important case studies from the last 12 months.
Kontakt
Jenny Barlow;     Tel.: [1 212 537 5898];     Email: info@hansonwade.com
42.
 
21st Congress of the EAHP
ID
727574
Termin
16. Mär 2016 - 18. Mär 2016
Ort
Wien, Österreich
Zusammenfassung
"Hospital Pharmacists taking the lead – partnerships and technologies" will be the theme for the presentations at the Vienna 2016 EAHP Congress. A scientific programme including 3 keynote presentations, 15 seminars EAHP’s Congress is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education, as well as by some of its national member associations according to the different national accreditation systems. open for interactions with the speakers and 6 interactive workshops will offer participants the unique opportunity to meet, network and share expertise. EAHP’s industry partners have also committed to conducting satellite symposia highlighting new developments important to hospital pharmacy.
43.
 
The Second Menactrims Congress — MENACTRIMS (Middle East North Africa Committee for Treatment and Research in Multiple Sclerosis)
ID
742737
Termin
17. Mär 2016 - 19. Mär 2016
Ort
Amman, Jordanien
Zusammenfassung
The congress aim is to provide a forum of excellence in MS education and research. Building on the collective efforts of the scientific committee, the meeting will deliver state-of-the-art presentations on MS by renowned international and regional keynote speakers. The content of the meeting includes up to date information on the latest treatments, clinical research, therapeutic strategies, imaging, epidemiology, differential diagnosis, risk factors, pregnancy, and much more.The congress will convene over a two-day period to present major updates through plenary sessions, scientific symposia and teaching courses. This year’s congress will also feature parallel sessions addressed to nurses in collaboration with the International Organization of MS Nurses (IOMSN) and the Consortium of Multiple Sclerosis Centers (CMSC), and to regional MS societies in collaboration with the MS International Federation (MSIF). In addition, the European Charcot Foundation will participate in the meeting for the first time through a scientific symposium.
Kontakt
Basil kadara;     Tel.: [+971 4 453 2975];     Email: contact@diaedu.com
Themen
• Recent advances in MS therapy • MS and the Environment • Update review of MRI in MS • Immunology of MS • Epidemiology of MS • Differential Diagnosis of MS • Update on Secondary Progressive MS • Neuromyelitis Optica • Pediatric MS • MS and pregnancy • Symptomatic Management of MS
44.
 
INTERNATIONAL CONFERENCE OF PHARMACY AND HEALTH SCIENCES 2016
ID
745872
Termin
18. Mär 2016 - 20. Mär 2016
Ort
Ipoh, Malaysia
Zusammenfassung
ICPHS 2016 The International Conference of Pharmacy and Health Sciences 2016 (ICPHS 2016) is scheduled on 18-20th March 2016 at Casuarina@Meru, Ipoh, Perak, Malaysia. The conference will feature globally renowned speakers and delegates from academia, research centres and industry to share insights to overcome challenges in the field of Pharmacy Practice (Clinical and Community Pharmacy, Natural Products (Nutraceuticals and Cosmetics), Nanotechnology, Industrial Pharmacy and Education in pharmaceutical sciences. This conference provides an ideal opportunity to researchers, academicians, practitioners, industry players, health professionals, policy-makers and students to upgrade their knowledge by attending various scientific sessions. The Chair and Co-chair look forward to your involvement at this highly anticipated and vital event.
45.
 
HIV Vaccines
ID
740208
Termin
20. Mär 2016 - 24. Mär 2016
Ort
Olympic Valley, Vereinigte Staaten
Zusammenfassung
HIV Persistence: Pathogenesis and Eradication. The development of a safe and effective HIV vaccine remains a major global health priority and a complex problem to solve. Current efforts emphasize an ability to elicit systemic and mucosal antibody responses capable of preventing the acquisition of infection. Evidence from multiple passive transfer experiments in non-human primates, as well as from studies of immunologic correlates of modest efficacy in the RV144 Thai trial, support the notion that both neutralizing and non-neutralizing antibodies have potential to prevent infection. Major advances have been made in understanding the epitopes, structures and evolutionary pathways of broadly neutralizing antibodies, leading to new avenues to pursue for vaccine design. The extraordinary breadth and potency of some recently discovered neutralizing antibodies has generated additional interest in potential therapeutic applications, including cure strategies. There has also been a steady increase in knowledge of other types of antiviral antibodies and their effector functions that may be important for vaccines. This meeting aims to cover a range of topics including: 1) Initial virus transmission events for vaccine intervention, 2) Non-neutralizing antibody correlates of sterilizing immunity; 3) Epitopes, structures and ontogeny of broadly neutralizing antibodies; 4) Novel vaccine concepts for broadly neutralizing antibody induction; and 5) Immunotherapy. Emphasis will be placed on recent unpublished findings in key areas that hold the greatest promise for rapid progress toward an effective vaccine.
Verwandte Fachgebiete
46.
 
Biomarker Summit 2016
ID
744545
Termin
21. Mär 2016 - 23. Mär 2016
Ort
San Diego, Vereinigte Staaten
Zusammenfassung
The Biomarker Summit 2016, to be held on March 21-23, 2016 in San Diego, CA at the Westin San Diego Hotel
Kontakt
Kristen Starkey;     Tel.: [6262566405];     Email: infogtcbio@gtcbio.com
Themen
Oncology Biomarkers, Neurological Biomarkers, Inflammatory & Immunological Biomarkers
Verwandte Fachgebiete
47.
 
Biomarker Summit
ID
744929
Termin
21. Mär 2016 - 23. Mär 2016
Ort
San Diego, Vereinigte Staaten
Zusammenfassung
The Biomarker Summit is a meeting place for leaders in the field to discuss the issues and challenges scientists and researchers face in all aspects of the biomarker and diagnostic development process from discovery to translation to commercialization. A wide variety of important topics will be covered including biomarker identification, validation, and translation strategies, bioinformatics and systems biology approaches to personalized medicine, big data analytics and management, regulatory and reimbursement trends, companion diagnostics development, and much more. Through scientific presentations, case studies and panel discussions, these areas will be addressed in an intimate and highly interactive environment with perspectives from industry, academia and the public sector. Assembling leading scientists, researchers, decision-makers and other players across the industry spectrum, the Summit provides a unique opportunity to gain the latest biomarker developments.
48.
 
Inflammatory & Immunological Biomarkers Conference
ID
744958
Termin
21. Mär 2016 - 23. Mär 2016
Ort
San Diego, Vereinigte Staaten
Zusammenfassung
This conference will cover both inflammatory and immunological biomarkers in a wide variety of disease areas. The unmet medical needs in autoimmune diseases, respiratory diseases, kidney disease, lupus, IBD and other inflammatory diseases will be discussed. Presentations and case studies from both industry and academia will cover predictive biomarkers, surrogate endpoints and improving clinical trials as it relates to both drug and diagnostic development. This is an opportunity to listen to recent updates on research, share ideas with colleagues, and network with experts in inflammatory and immunological biomarkers. 
49.
 
Neurological Biomarkers Conference
ID
744891
Termin
21. Mär 2016 - 23. Mär 2016
Ort
San Diego, Vereinigte Staaten
Zusammenfassung
This conference focuses on the development of CNS biomarkers for drugs and diagnostics from CSF and Blood, as well as imaging approaches. Scientific data, updates and case studies in neurological and neurodegenerative disorders will be presented on disease areas such as Alzheimer's, Parkinson's and Huntington's. Biomarker challenges for neuropsychiatric disorders such as autism, schizophrenia, depression and mood disorder will also be explored. Attend this event for the opportunity to listen to recent updates on research, share ideas with colleagues, and network with experts to advance biomarker discovery and development. 
50.
 
Ocular Diseases Drug Discovery Conference
ID
744967
Termin
22. Mär 2016 - 23. Mär 2016
Ort
San Diego, Vereinigte Staaten
Zusammenfassung
Novel therapeutics from the nanotechnology scope are on the rise. The progress in drug and gene-loaded particles that adequately pass through the mucus barriers provides better delivery to ocular tissue. Recent developments in gene therapies with sustained release of a protein have shown promising results with lesser side effects in patients. The event aims to gather leading scientists, researchers, and experts to discuss and collaborate on combating and curing age-related macular degeneration (AMD), diabetic retinopathy, glaucoma, diabetic macular edema (DME), and other ocular diseases. Other hot topics include PRINT® platform for intraocular prostaglandin formulation, coating technology, anti-angiogenic mechanisms and much more!
51.
 
MENAPharExcCong — MENA Pharma Excellence Congress
ID
762640
Termin
28. Mär 2016 - 31. Mär 2016
Ort
Dubai, Vereinigte Arabische Emirate
Zusammenfassung
The MENA Pharmaceutical Excellence Congress is the premier platform for the pharmaceutical industry and attracts senior local, regional and international leaders from the pharmaceutical industry and government representatives to discuss key issues facing the pharmaceutical industry through a number of interactive presentations, panel discussions and on-stage interviews.

Delegates will have the opportunity to hear from leading experts from across the region and the globe who will discuss the current regulatory environment in the region, key challenges facing the pharmaceutical companies such as pricing, reimbursement and market access, creating successful business models to drive growth for the industry, improving sales and marketing effectiveness by using the latest trends in technologies and creating effective partnership to strengthen relation with the key stakeholders.

Kontakt
yvette aldeguer;     Email: yvettelourdes5@gmail.com
52.
 
COLD CHAIN — Middle East Pharma Cold Chain Congress
ID
770796
Termin
28. Mär 2016 - 31. Mär 2016
Ort
Dubai, Vereinigte Arabische Emirate
Zusammenfassung
The Middle East Pharma Cold Chain Congress provides a regional platform that connects industry stakeholders to share their ideas on issues and challenges the industry faces. The congress will bring to fore solutions and strategies that will ultimately ensure healthy shipments and safe pharmaceuticals throughout the region.
Kontakt
mohammed el shammy;     Tel.: [+97143619616];     Email: info@pharmacoldchainme.com
Themen
cold chain
53.
 
Modern Phenotypic Drug Discovery: Defining the Path Forward
ID
743867
Termin
02. Apr 2016 - 06. Apr 2016
Ort
Big Sky, Vereinigte Staaten
Zusammenfassung
Innovation and productivity in pharmaceutical drug discovery have been below expectations. Surprisingly, more first-in-class small molecule drugs approved by the FDA (1999-2008) were identified by functional approaches reminiscent of pre-genomics pharmacology (phenotypic drug discovery) than by contemporary molecular targeted strategies. This observation, and the unexpected difficulties of target validation, have diminished the impact of the “genomics revolution” and are arguably associated with the decline in innovation and productivity of pharmaceutical research. As a result, pharmaceutical researchers have begun to reevaluate the “Molecular Mindset” which has dominated our collective drug-hunting culture, and explore modern approaches to phenotypic screening. However, there is currently no single scientific forum where scientists from pharma, biotech, academia and instrument/service providers can meet and discuss strategies/issues related to phenotypic drug discovery (PDD). In part, this is because PDD encompasses multiple therapeutic areas and involves diverse disciplines including drug discovery, chemistry, cell biology, stem cell biology, systems biology, genomics, bioengineering and informatics. This Keystone Symposia meeting uniquely provides this interdisciplinary environment and is a particularly attractive venue given the increasing role of academia in drug discovery research. The conference will be a forum for the global PDD research community in which scientists from diverse institutions and scientific disciplines can meet to share/discuss/debate topics related to advantages/disadvantages of PDD and how PDD can complement targeted approaches. Significantly, the conference will provide a much needed forum for the growing interest in PDD, and can conceivably become the cornerstone of the global scientific movement for the reintroduction of functional biology/physiology-driven pharmaceutical research.
Verwandte Fachgebiete
54.
 
Oligo 2016
ID
740238
Beginn
06. Apr 2016
Ort
Oxford, Großbritannien
Zusammenfassung
We are delighted to announce our second Oxford Symposium on antisense and therapeutic oligonucleotides.  The symposium is aimed at bringing together chemists and biologists from academia and industry to discuss the latest advances and breakthroughs in the development of synthetic oligonucleotides as therapeutics.
Verwandte Fachgebiete
55.
 
Manufacturing of Biologics and Biosimilars
ID
785581
Termin
14. Apr 2016 - 15. Apr 2016
Ort
München, Deutschland
Kontakt
Andrea Weber;     Email: andrea.weber@fleming.events
56.
 
New Therapeutics for Diabetes and Obesity
ID
743870
Termin
17. Apr 2016 - 20. Apr 2016
Ort
La Jolla, Vereinigte Staaten
Zusammenfassung
Type 2 diabetes (T2DM) is a global pandemic with approximately 350 million patients worldwide, driven largely by increasing prevalence of obesity. Multiple options exist for treatment of the primary disease and the array of associated cardiovascular disorders. Nonetheless, the majority of patients do not reach recommended glycemic goals, and there is an urgent need for more efficacious, cost-effective and safe therapies. The regulatory hurdle for new drugs is sizable and challenged by the specific requirement for cardiovascular mortality study. Given the magnitude of the challenges, highly collaborative efforts involving academia, biotech, pharma, regulatory agencies, patient advocacy groups and other key stakeholders are required to identify and advance new therapies that are substantially differentiated from current disease management. The major goals of this meeting are to: 1) Define the distance between current therapy relative to what is most needed to address successfully the near-term challenges of the disease and the wave of later-stage disease-specific complications; 2) Communicate the most important scientific advances in metabolic diseases with the intimate details that often escape peer-review publication and are seminal to drug R&D; and 3) Create opportunities for candid discussion among key stakeholders (academia, biotech, industry, regulatory, venture community, etc.) to identify new business processes, along with new science to streamline the successful conversion of ideas to medicines. Is it anticipated that the perspectives and science presented at this meeting, together with multiple platforms for discussion and interaction, will facilitate the identification of collaborations and opportunities for the discovery of transformative treatment of diabetes and related disorders. The meeting will be uniquely led by experienced drug-hunters with world-class academic credentials to help foster the translation of basic science to breakthrough therapeutics. We anticipate that this meeting will be of interest to a broad and diverse group of individuals interested in drug discovery and cost-effective development with an emphasis on quality, speed and value.
Verwandte Fachgebiete
57.
 
3rd Annual Peptides Congress
ID
742812
Termin
18. Apr 2016 - 19. Apr 2016
Ort
London, Großbritannien
Zusammenfassung
Oxford Global’s highly anticipated event offers a unique opportunity for over 400 biologics experts to discuss novel peptide research results and case studies in peptide therapeutics. Co-located with the highly established Proteins & Antibodies Congress and Biosimilars & Biobetters Congress.
Kontakt
Guillaume Alsonso;     Tel.: [+44 (0)1865 248455];     Email: g.alonso@oxfordglobal.co.uk
Themen
Peptide synthesis, Peptide manufacturing, Peptide development, Peptide research, Peptide technologies, Peptide applications, Peptide formulation, Peptide arrays, Peptide modification
58.
 
4th Annual Biosimilars & Biobetters Congress
ID
748198
Termin
18. Apr 2016 - 19. Apr 2016
Ort
London, Großbritannien
Zusammenfassung
Oxford Global are proud to present our 4th Annual Biosimilars & Biobetters Congress, taking place on the 18th & 19th April 2016 in London. This exciting event will address key topics in development and commercial issues including emerging markets, regulation, interchangeability, and development case studies.
Kontakt
Danielle Dalby;     Tel.: [+44 (0)1865 248455];     Email: d.dalby@oxfordglobal.co.uk
Themen
biosimilars, biosimilar, biobetters, biobetter, biosuperiors, commercial affairs, clinical development, follow-on biologics, biologics development, strategic marketing, regulatory affairs, legal affairs, commercial development, medical affairs, market access, stability testing, trial design, biologics, generics, biologics manufacturing, strategy planning, quality assurance, clinical outsourcing, characterisation, extrapolation, assay development
59.
 
DCH — Drug Discovery Chemistry
ID
784772
Termin
19. Apr 2016 - 22. Apr 2016
Ort
San Diego, Kalifornien, Vereinigte Staaten
Zusammenfassung
Drug Discovery Chemistry is a dynamic conference for medicinal chemists working in pharma and biotech. Focused on discovery and optimization challenges of small molecule drug candidates, this event provides many exciting opportunities for scientists to create a unique program according to personal interests. New for 2016 will be the addition of three symposia on Friday covering the blood-brain barrier, biophysical approaches for drug discovery, and antivirals.
Kontakt
Tel.: [7819725400];     Email: chi@healthtech.com
Themen
drug discovery, drug development, chemistry, proteins, peptides, macrocyclics
60.
 
World Orphan Drug Congress USA 2016
ID
728958
Termin
20. Apr 2016 - 22. Apr 2016
Ort
Washington, DC, Vereinigte Staaten
Zusammenfassung
This is the largest global industry gathering for the orphan drug industry and rare disease community where pharma, biotech, patient groups, academia, regulators, payers and investors gather to talk about strategies to expedite orphan drug development. We grew the event to 600 participants in 2015 with over 25 countries represented. cademic medical centers, HCPs, clinicians and point of care diagnostics will be a new focus in 2016. Specific orphan products and their Marketing Managers will also be a stronger focus along with gene therapy as the future rare disease cure. Meet CEOs, VPs and Directors of the following business units from pharma and biotech: R&D, Business Development, Regulatory Access, Market Access, Commercial, Marketing and Brand/Product Managers.You will also meet Scientists, Investigators and Engineers as well as relevant Heads from university departments studying rare disease and developing a cure.
Kontakt
Freya Smale;     Tel.: [646-619-1811];     Email: freya.smale@terrapinn.com
Themen
In terms of content, people are talking more and more about gene therapy orphan drugs. 2016 will feature the latest content on gene therapy orphan drugs in development. The other new addition to 2016 is a workshop for clinicians. This workshop is designed to enable marketers to help clinicians get educated on rare diseases and orphan drugs so they can detect and diagnose rare diseases better and faster.
61.
 
8th International Congress of Psychopharmacology & 4th International Symposium on Child and Adolescent Psychopharmacology
ID
745895
Termin
20. Apr 2016 - 24. Apr 2016
Ort
Antalya, Türkei
Verwandte Fachgebiete
62.
 
CPhI CAPA & Root Cause Investigation Workshop
ID
782995
Termin
21. Apr 2016 - 22. Apr 2016
Ort
Mumbai, Indien
Zusammenfassung
CPhI's CAPA & Root Cause Investigation Workshop is the only forum in India dedicated to identifying non-compliance, understanding the root cause, and responding with appropriate corrective and preventive actions for the Pharmaceutical companies. It is an exclusive workshop mentored by Former USFDA Director on areas of quality and manufacturing in Pharma companies with focus on USFD's Quality System Guide, recent Warning Letters and EU-GMP Chapter 1 regulations.
Kontakt
Purvai Gupta;     Tel.: [+91-22-61727077];     Email: purvai.gupta@gmail.com
Themen
CAPA, Root Cause Analysis, Quality Management System, Quality, warning letter, corrective action, Pharma warning letters, 483s, Corrective action preventive action, deviation management, signal detection,
63.
 
Pharmaceutics-2016 — World Congress & Expo on Pharmaceutics & Drug Delivery Systems
ID
766156
Termin
21. Apr 2016 - 23. Apr 2016
Ort
Dubai, Vereinigte Arabische Emirate
Kontakt
Varun;     Tel.: [7799790001];     Email: pharma.congress@scientificfederation.com
Themen
Recent Innovations in Drug delivery technology, Drug Targeting, Nanotechnology in Drug Delivery Systems, Drug discovery and medicinal chemistry, Physiological Considerations of Drug Delivery, Advances in Biotherapeutics-Drug Discovery and Development
64.
 
Cancer and Autoimmunity 2016 — Emerging Target Therapies in Cancer & Autoimmunity
ID
738350
Termin
21. Apr 2016 - 25. Apr 2016
Ort
Varadero, Kuba
Zusammenfassung
The four-day event will bring together basic scientists, medicinal chemists, pharmacologists, biotechnologists, clinical investigators, and other allied professionals from around the world, interested in the fields of disease pathogenesis and new targeted therapies development for Cancer and for Autoimmune Disorders. The meeting will be an excellent opportunity to expose the translational nature of modern biomedical and pharmaceutical research.

One of the key objectives of the 2016 Symposium will be to arm delegates with the necessary tools that will enable them to make a difference, implement and take actions at all levels, in global fight against cancer or autoimmunity diseases.

Kontakt
Jesus Benitez;     Email: biomed@cigb.edu.cu
Themen
Molecular oncology; Tumor immunology; Cancer Immunotherapy, Clinical trials; Mechanisms of autoimmune-related diseases; Regulatory T cells and autoimmunity; Pharmacological strategies for treatment
Verwandte Fachgebiete
65.
 
Stem Cell Research & Regenerative Medicine Conference
ID
744921
Termin
25. Apr 2016 - 26. Apr 2016
Ort
Boston, Vereinigte Staaten
Zusammenfassung
This conference presents information regarding cutting-edge developments in all areas of stem cell research, including the biology, medicine, applications and regulations of stem cells. Topics of discussion include recent developments in pre-clinical and clinical trials of stem cell therapy, regenerative medicine and tissue engineering, cancer stem cells, immunotherapy, stem cell reprogramming, and regulatory policies regarding stem cell research.
66.
 
Pre-Filled Syringes East Coast
ID
770754
Termin
25. Apr 2016 - 26. Apr 2016
Ort
Iseline, New Jersey, Vereinigte Staaten
Zusammenfassung
Through a combination of powerful keynote addresses, topical debate and interactive workshops, Pre-Filled Syringes East Coast will once again play host to an audience of senior scientists, device manufacturers and PFS market professionals, providing a focal point to discuss the latest innovations and developments in pre-filled syringes; as well as honing in on industry challenges and regulatory compliance.
Kontakt
Teri Arri;     Tel.: [+44 (0)20 7827 6000];     Email: tarri@smi-online.co.uk
Themen
prefilled syringes, autoinjectors, human factors, extractables, leachables, patient safety, compliance, biosimilar, parenteral, packaging, injectable devices, drug device, drug delivery, combination products, sterilization, needle, component, glass syringe, cop syringe, container, formulation, manufacturing, medical device, parenteral drug, plastics, quality by design
67.
 
Stem Cell Summit
ID
744986
Termin
25. Apr 2016 - 27. Apr 2016
Ort
Boston, Vereinigte Staaten
Zusammenfassung
Stem Cell Summit provides cutting-edge information on developments in all areas of stem cell research from bench to bedside, including the biology, medicine, applications, regulations, product development, and the commercialization of stem cells. Recent developments in pre-clinical and clinical trials of stem cell therapy, regenerative medicine and tissue engineering, cancer stem cells, immunotherapy, stem cell reprogramming, regulatory policies regarding stem cell research, and manufacturing will all be discussed. Business opportunities, challenges, and potential strategies for overcoming these challenges will also be addressed.
68.
 
2016 Diabetes Summit — 2016 Diabetes Summit
ID
766515
Termin
25. Apr 2016 - 27. Apr 2016
Ort
Boston, Vereinigte Staaten
Zusammenfassung
GTCbio and the advisory board would like to invite you to the 2016 Diabetes Summit to be held April 25-27, 2016 in Boston, MA. This unique event encompasses the drug discovery and partnering aspects of diabetes in two individual conferences that take place concurrently: 9th Diabetes Drug Discovery & Development Conference & 6th Diabetes Partnering & Deal-Making Conference.
Kontakt
Kristen Starkey;     Tel.: [16262566405];     Email: infogtcbio@gtcbio.com
Verwandte Fachgebiete
69.
 
Lyophilization USA
ID
781422
Termin
27. Apr 2016 - 28. Apr 2016
Ort
Iselin, Vereinigte Staaten
Zusammenfassung
Lyophilization USA 2016 will gather leading market experts to discuss the latest cutting edge developments in freeze drying as well as solutions to on-going industry challenges. The packed agenda features a mix of case study led presentations, panel debates, interactive workshops and keynote addresses that have been tailored for an audience of professionals working in pharmaceutical lyophilization from formulation development through to production and quality assurance. Featured Speakers include Pfizer, Genzyme, Allergan, Novo Nordisk A / S, Johnson & Johnson, Steritech Solutions LLC, Biogen Idec, Momenta Pharmaceuticals, PLUS MANY MORE!
Kontakt
Teri Arri;     Tel.: [+442078276000];     Email: tarri@smi-online.co.uk
Themen
lyophilisation, quality by design, freeze drying, scale-up, validation, spray drying, Process Analytical Techniques, PAT, robustness, stability, delivery, optimisation, protein stabilisation, design strategies, maintenance, automatic loading and unloading, lyophilization, qbd, protein, optimization, aseptic, fill/finish, temperature, drying, powder, nucleation, sterilization, injectables, thaw, storage, crystallization, formulation, parenteral
70.
 
Malaria Vaccines for the World MVW 2016
ID
758848
Termin
02. Mai 2016 - 04. Mai 2016
Ort
Leiden, Niederlande
Zusammenfassung
With more an estimated 200 million clinical cases annually, resulting in more than 580,000 deaths, malaria is not only an important global health problem but also a major factor limiting economic development in developing countries. Interventions that deploy an effective malaria vaccine are regarded as being one of the most cost-effective and reliable means to limit and ultimately eradicate the disease. In recent years, due to increased funding and research, malaria vaccine development has greatly accelerated. The MVW 2016 conference will look at different aspects of vaccine development, assessment and deployment, as well as funding and regulatory aspects of vaccine implementation and testing. The conference will also highlight research on the use of animal models and (controlled) clinical trials to study the immunological basis of protection and to identify novel candidate vaccine antigens.
Verwandte Fachgebiete
71.
 
Adverse Drug Reactions, Drug Interactions and Pharmacovigilance Course
ID
722686
Termin
09. Mai 2016 - 13. Mai 2016
Ort
Oxford, Großbritannien
Kontakt
Course Administrator;     Tel.: [01865 286955];     Email: expther@conted.ox.ac.uk
72.
 
10th Drug Design & Medicinal Chemistry Conference
ID
765257
Termin
11. Mai 2016 - 12. Mai 2016
Ort
Berlin, Deutschland
Zusammenfassung
We are excited to announce the 10th Drug Design & Medicinal Chemistry Conference, to be held May 11-12, 2016 in Berlin, Germany. This meeting will provide a multi-disciplinary forum for industry and academia colleagues to gather and explore the changing landscape of drug discovery in emerging target classes and chemical biology approaches for discovering new medicines. Leaders in the field will present on hot topics such as protein-protein interactions, overcoming resistance in drug design, allosteric inhibitors, and many more. Attendees will also have the opportunity to meet colleagues during dedicated networking sessions and form new connections.
Kontakt
Kristen Starkey;     Tel.: [626-256-6405];     Email: infogtcbio@gtcbio.com
Themen
Drug Design, Medicinal Chemistry
73.
 
3rd 3D Models & Drug Screening Conference
ID
787029
Termin
11. Mai 2016 - 12. Mai 2016
Ort
Berlin, Deutschland
Zusammenfassung
GTCbio is proud to present the 3rd 3D Models & Drug Screening Conference, to be held on May 11-12, 2016 in Berlin, Germany.
Kontakt
Kristen Starkey;     Tel.: [6262566405];     Email: infogtcbio@gtcbio.com
74.
 
European Pharma Summit 2016
ID
786951
Termin
11. Mai 2016 - 13. Mai 2016
Ort
Berlin, Deutschland
Zusammenfassung
We invite you to attend the European Pharma Summit 2016, which will take place on May 11-13, 2016 in Berlin, Germany.
Kontakt
Kristen Starkey;     Tel.: [6262566405];     Email: infogtcbio@gtcbio.com
75.
 
3rd GPCR Targeted Screening Conference
ID
786994
Termin
12. Mai 2016 - 13. Mai 2016
Ort
Berlin, Deutschland
Zusammenfassung
We invite you to attend the 3rd GPCR Targeted Screening Conference, which will take place on May 12-13, 2016 in Berlin, Germany.
Kontakt
Kristen Starkey;     Tel.: [6262566405];     Email: infogtcbio@gtcbio.com
Themen
GPCR, Targeted, Screening
76.
 
VI EWDSy — Sixth European Workshop in Drug Synthesis
ID
779961
Termin
15. Mai 2016 - 19. Mai 2016
Ort
Siena, Italien
Kontakt
Email: ewdsy.siena@gmail.com
Themen
drug synthesis, HIV, neglected diseases, ADMET, toxicology, organic chemistry, catalysis
77.
 
2nd Annual Formulation & Drug Delivery Congress 2016
ID
748240
Termin
18. Mai 2016 - 19. Mai 2016
Ort
London, Großbritannien
Zusammenfassung
Oxford Global are delighted to announce the 2nd Annual Formulation & Drug Delivery Congress, 18 – 19 May 2016, London, UK. Over 150 delegates representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic institutions will discuss over 40 presentations and case studies focused on the key issues in biologics and small molecule drug formulation and delivery.
Kontakt
Guillaume Alonso;     Tel.: [+44 (0)1865 248 455];     Email: g.alonso@oxfordglobal.co.uk
Themen
Biologics, Formulation, Drug Delivery, Biologics, Small Molecule, Nanoparicle,
78.
 
Modern Vaccines/Adjuvants Formulation MVAF 2016
ID
758838
Termin
18. Mai 2016 - 20. Mai 2016
Ort
Copenhagen, Dänemark
Zusammenfassung
The increasing need for new and improved vaccines and the growing level of sophistication of their associated adjuvantation and delivery systems has major implications for the design, formulation, delivery, manufacturing and quality assessment of modern vaccines and immune interventions in general. MVAF 2016 will be the fifth meeting in this successful series and again will offer an international forum for the discussion of all aspects of vaccine and adjuvant formulation and will focus on: Innovation in vaccine design and adjuvantation/delivery technologies Challenges to manufacturing and the administration of modern vaccines Compliance with quality standards and regulatory requirements MVAF 2016 will then assess the impact of all of the above on the future development/design of vaccines and adjuvants.
Verwandte Fachgebiete
79.
 
Molecular Diagnostics World Summit 2016
ID
758998
Termin
19. Mai 2016 - 20. Mai 2016
Ort
London, Großbritannien
Zusammenfassung
The global molecular diagnostics market is predicted to reach $8 billion by 2018. This market is highly influenced by the raise of infectious diseases such as TB, HIV etc, antimicrobial resistance and other factors. 80% of the market are shared between Europe and America and remaining 20% between Rest of the World. To provide efficient treatment and disease management there is an urgent need for rapid and more efficient diagnostics. In terms of technology PCR based diagnostics are rapidly growing and possess the major market shares. NGS, POC, Microarrays and others form the rest of the market. Molecular Diagnostics market comprises of instruments, reagents, software and end user services which has a great future and growth by 2018. Thus, Molecular Diagnostics World Summit 2016, conference offers a rare opportunity to its participants to understand and learn from top experts in the Molecular Microbiology and Diagnostics field and to share ideas and develop new business collaborations. The conference will also provide a platform to discuss the current vital issues, market assessment, commercialization and globalization.
Verwandte Fachgebiete
80.
 
New Approaches to Vaccines for Human and Veterinary Tropical Diseases
ID
743978
Termin
22. Mai 2016 - 26. Mai 2016
Ort
Kapstadt, Südafrika
Zusammenfassung
Human and livestock vaccines can contribute to improved human welfare and income generation by maintaining human health and meeting the demand for meat, milk and fish in developing countries. All of these factors contribute to the growing importance of improving food safety, availability and nutritional security. An important component of this Keystone Symposia meeting will be to stimulate crosstalk between the human and veterinary vaccine communities by highlighting cross-cutting technical advances and new science and knowledge from laboratory and field research. The meeting will also provide a rare opportunity for scientists from the Northern and Southern hemispheres to interact and pool resources and knowledge in the common fight against tropical diseases.
81.
 
3rd NovAliX Conference - Biophysics in Drug Discovery 2016
ID
788763
Termin
07. Jun 2016 - 10. Jun 2016
Ort
Straßburg, Frankreich
82.
 
ECI — Vaccine Technology VI
ID
738403
Termin
12. Jun 2016 - 17. Jun 2016
Ort
Cetraro, Calabria, Italien
Zusammenfassung
This conference series addresses technical and scientific issues in the development and manufacturing of vaccines. It will also discuss broader issues related to vaccine development and access that will be of interest to institutional and academic participants. Emphasis will be particularly placed on emerging diseases and developing world.
Kontakt
Arlene Conway;     Tel.: [212 514 6760];     Email: info@rngconfintl.org
Themen
Break through developments in vaccinology •Issues and case studies in process development •Formulating and delivering vaccines •Vaccine characterization/analytics •Therapeutic vaccines •Case studies •New challenges, new technologies in vaccine development. •One world, one health
83.
 
Vaccine Technology VI
ID
721611
Termin
12. Jun 2016 - 17. Jun 2016
Ort
Albufeira, Portugal
Kontakt
ARLENE CONWAY;     Tel.: [2125146760];     Email: info@engconfintl.org
Themen
In line with previous years, session topics will focus on all aspects of vaccine technology. This will include: •early antigen discovery and design •process development •analytics •clinical trials •commercialization.
84.
 
17th Annual Drug Discovery Leaders Summit 2016
ID
774013
Termin
13. Jun 2016 - 14. Jun 2016
Ort
Berlin, Deutschland
Zusammenfassung
Oxford Global’s 17th Annual Drug Discovery Leaders Summit and our co-located 4th Annual Discovery Chemistry and Drug Design Congress is Europe’s leading Summit in the drug discovery and discovery chemistry field. Our prestigious Summit brings together prominent decision makers working at the forefront of research into target based discovery, phenotypic screening, medicinal chemistry and drug design.
Kontakt
Guillaume Alonso;     Tel.: [+44 (0)1865 248 455];     Email: g.alonso@oxfordglobal.co.uk
Themen
Target Based Discovery, Screening and Assays: Enabling Technologies, Novel Therapeutic Modalities, Supporting Innovation: Data and Information Management, Discovery Chemistry: Latest Case Studies, Drug Design: Novel Approaches, Large Molecule Discovery Approaches
85.
 
6th RSC / SCI symposium on GPCRs in Medicinal Chemistry
ID
740202
Termin
13. Jun 2016 - 15. Jun 2016
Ort
Verona, Italien
Zusammenfassung
The key role of G-protein coupled receptors (GPCRs) in human disease underpins their importance to modern medicine. We are pleased to announce that Aptuit, Italy will support the sixth meeting in this series on GPCR drug discovery, which will combine cutting edge medicinal chemistry with innovative structural biology and novel drug design approaches.
86.
 
Clinical Quality & Compliance Masterclass
ID
785604
Termin
16. Jun 2016 - 17. Jun 2016
Ort
Wien, Österreich
Kontakt
Andrea Weber;     Email: andrea.weber@fleming.events
Themen
On the journey to clinical quality improvements at the site level, Inspection readiness for clinical & pharmacovigilance audits, Embracing QRM, QbD and RbM approaches to clinical quality, Third-party quality oversight
Verwandte Fachgebiete
87.
 
Clinical Quality & Compliance Masterclass
ID
785594
Termin
16. Jun 2016 - 17. Jun 2016
Ort
Amsterdam, Niederlande
Kontakt
Andrea Weber;     Email: andrea.weber@fleming.events
Themen
On the journey to clinical quality improvements at the site level, Inspection readiness for clinical & pharmacovigilance audits, Embracing QRM, QbD and RbM approaches to clinical quality, Third-party quality oversight
Verwandte Fachgebiete
88.
 
CMS3 — Advanced Topics on Cell Model Systems
ID
789574
Termin
20. Jun 2016 - 24. Jun 2016
Ort
Rom, Italien
Zusammenfassung
An intensive one week laboratory and lecturer school for PhD students and young researchers in the Eternal City Rome to facilitate an effective sharing and dissemination of new and innovative research ideas, strategies, focal points on cell model systems to promote pharmaceutical, pharmacogenomics, tissue engineering and computational research together with twelve outstanding scientists from different countries: Germany, Israel, Italy, Switzerland, United Kingdom. Fiftheen scientists of the Research Establishment of National Research Council (CNR) will impart practical exercises at laboratories on techniques in model membrane systems, optical microscopy, Raman and IR spectroscopy, nanostructures and biosensors, and dynamic molecular simulation. No other schools are present in Europe on this specific topic and mixing of theoretical and practical approaches.The school is certified as UNI EN ISO 9001:2000. The management respects the standard procedure and quality of international level. Participants must have a degree in either: Physics, Mathematics, Chemistry, Engineering, Biology or Medicine and a basic working knowledge of experimental research. Preference will be given to Ph.D. students and junior scientists under 35 and to those having not more then five years research experience. Applicants should send their current CV to the School Secretariat by email to: cms3.cnr@gmail.com , together with a formal signed letter of recommendation from a Professor who is aware of their work. The CV should include details of academic qualifications and a list of scientific publications as well as a short description of their current scientific research. Closing date for applications: May 6th, 2016. Registration fee:150 eur per person. It includes all academic sessions, course material, daily coffee-break and lunch (without drinks), social programme and certificate of completation.
Kontakt
Alfonsina Ramundo Orlando;     Tel.: [+39 (0)6 45488213];     Email: cms3.cnr@gmail.com
Themen
Cell model systems, Biophysics, Pharmacology, Imaging, Bio-sensors, Molecular Dynamic Simulations
Verwandte Fachgebiete
89.
 
Pharmacovigilance Europe 2016
ID
759884
Termin
21. Jun 2016 - 22. Jun 2016
Ort
London, Großbritannien
Zusammenfassung
The  Pharmacovigilance Europe 2016  conference will participants an opportunity and a platform to share experiences with the likeminded individuals in the field. The conference will also provide an insight into the complexities and challenges impacting public safety and risk management, focusing mainly on drugs, biologics and medical devices and the future of PV in the globalization era.
90.
 
5th Annual Drug Repositioning, Repurposing and Rescue Conference
ID
759926
Termin
21. Jun 2016 - 22. Jun 2016
Ort
Chicago, Vereinigte Staaten
91.
 
International Scientific Conference on Probiotics and Prebiotics - IPC2016
ID
745918
Termin
21. Jun 2016 - 23. Jun 2016
Ort
Budapest, Ungarn
Zusammenfassung
IPC2016 is the biggest scientific conference worldwide, solely focusing on probiotics and prebiotics for scientists, researchers, product developers, industry participants, pharmaceutical, medical, health and regulatory professionals as well as venture capitalists and investors.  The aim of the conference is to learn about recent advances, likely future developments and to exchange scientific ideas and experiences in our field – all within a unique environment. It is our intention to further confirm IPC as the leading scientific conference on probiotics and prebiotics. Every year the conference attracts up to  500 leading scientists,  opinion leaders, clinical study managers, medical doctors and dietitians from  more than 80 countries.
92.
 
Virus-Like Particle & Nano-Particle Vaccines VLPNPV 2016
ID
760078
Termin
22. Jun 2016 - 24. Jun 2016
Ort
Leiden, Niederlande
Zusammenfassung
Virus-like particles are supra-molecular assemblages incorporating key immunologic features of viruses which include repetitive surfaces, particulate structures with potential for induction of innate immunity through activation of pathogen-associated molecular-pattern recognition receptors. They carry no replicative genetic information and can be produced in heterologous expression systems at large scale. Virus-like particles thus represent a safe and effective vaccine platform with potential to induce potent B- and T-cell responses. In addition to being effective vaccines against the corresponding viruses from which they are derived, virus-like particles can also be used to present foreign epitopes to the immune system. This can be achieved by genetic fusion or chemical conjugation. This technological innovation has greatly broadened the scope of their use, from immunizing against microbial pathogens to immunotherapy for chronic diseases. Towards this end, virus-like particles have been used to induce auto-antibodies to disease-associated self-molecules involved in chronic diseases, such as hypertension and Alzheimer’s disease. The recognition of the potent immunogenicity and commercial potential for virus-like particles has greatly accelerated research and development activities. During the last decade, two prophylactic virus-like particle vaccines have been registered for human use, while another 12 vaccines entered clinical development. VLPNPV 2016 is the third meeting in this new series for international researchers working on Virus-Like Particles (VLPs) and Nano-Particle Vaccines (NPVs).
93.
 
RICT 2016 — Interfacing Chemical Biology and Drug Discovery
ID
788701
Termin
06. Jul 2016 - 09. Jul 2016
Ort
Caen, Frankreich
94.
 
Asia-Pacific Pharma Congress
ID
726913
Termin
14. Jul 2016 - 16. Jul 2016
Ort
Kuala Lumpur, Malaysia
Zusammenfassung
Asia Pharma-2016 is supported with related journals and their editorial board members which provide a chance of meeting them, along with experts in Medicine, Pharmacological sciences and Pharmaceutical sciences.Asia Pharma-2016 will be a great event where experts from universities, top Pharmaceutical industries, research centers and from the societies and association related to Pharmaceuticals. So, all are whole heartedly invited to be a part of this conference.
Kontakt
Robert Brown;     Tel.: [1-650-268-9744];     Email: asiapharma@pharmaceuticalconferences.com
Themen
IPR and Regulatory Affairs, Pharmacognosy, Pharmaceutics, Nanotechnology, Industrial Pharmacy, Pharmacology, Pharmaceutical Chemistry, Pharmaceutical Analysis, Pharmaceutical Microbiology, Pharmaceutical Biotechnology, Biochemistry, Hospital and Clinical Pharmacy.
95.
 
FASEB SRC: Translational Neuroimmunology: From Mechanisms to Therapeutics
ID
786115
Termin
24. Jul 2016 - 29. Jul 2016
Ort
Big Sky, Montana, Vereinigte Staaten
Zusammenfassung
This FASEB Science Research Conference will bring a greater understanding of the biochemical and molecular mechanisms underlying diseases associated with dysfunction in the neuroimmune system will undoubtedly facilitate the translational aspect of this field as novel therapeutic targets are moved towards human clinical trials. This will be facilitated by cutting-edge talks from scientists with international reputations on the topics of 1) CNS Metabolism and the Microbiome; 2) Inflammation in the Peripheral Nervous System; 3) Stem Cells and Neuroinflammation; 4) Neuroinflammatory Mechanisms of Demyelinating Diseases; 5) Immunity and Neurodegenerative Diseases; 6) Pre-clinical Studies for CNS Neuroinflammatory Diseases; 7) Neuroinflammation and Neurotrauma; 8) Neuroinflammation and Host Defense; and 9) The Many Faces of Microglia. In addition, this SRC will host a pre-meeting workshop entitled
Kontakt
FASEB SRC Staff;     Tel.: [3016347010];     Email: SRC@faseb.org
Verwandte Fachgebiete
96.
 
CSDD-2016 — II International Conference on Clinical Sciences and Drug Discovery
ID
790690
Termin
27. Jul 2016 - 29. Jul 2016
Ort
Dundee, Scotland, Großbritannien
Zusammenfassung
United Scientific group had successfully completed its first conference International conference on Clinical Sciences and Drug Discovery, in Baltimore USA, during November 02-04, 2015 (CSDD-2015). With this enthusiasm and prodigious success, we are proudly announcing the second conference International conference on Clinical Sciences and Drug Discovery -2016, Dundee, Scotland during July 27-29, 2016 (CSDD-2016) with a theme Drug discovery and development to clinical trials. Our focus lies on the translation of academic research findings into industry-driven drug development, Features including a world-class program of invited speakers from industry and academia, oral and poster presentations from submitted abstracts maintaining the same level of talks. Throughout the course of the three-day conference, you will get an exclusive opportunity to network and be involved in inspiring and interesting discussions of scientists and researchers on Antimicrobials: Bacterial, Fungal, Viral, Protozoal, Antineoplastic, Endocrinology and Metabolism, Hematological, CNS & ANS, Cardio-Vascular System, Respiratory, Nano therapeutics, Computer Aided Drug Designing, Structural Biology and many more research topics. The organizing committee is confident that participants will benefit from the high value scientific program. We welcome all the researchers to join us for these 3 days of stimulating discussions, knowledge sharing and networking event.
Kontakt
CSDD-2016 Committee;     Tel.: [408-426-4833];     Email: drugdiscovery@uniscigroup.org
Themen
Infectious: Bacteria, Fungi, Viruses, Protozoa, Neoplastic: Cancers, Tumours, and Lymphomas, Endocrinologic and Metabolic, Hematological, CNS & ANS, Cardiovascular, Respiratory, Immunological, Nano-Bio Therapeutics, Computer Aided Drug Design, Structural Biology, Medicinal Chemistry & Imaging
97.
 
IIR-cryobio-workshop — IIR Workshop on Cold Applications in Life Sciences
ID
789098
Termin
08. Sep 2016 - 09. Sep 2016
Ort
Dresden, Deutschland
Zusammenfassung
Cell/tissue cryopreservation and cold storage are central challenges e.g. in biobanking. Freezing and cryoprocessing are becoming increasingly important as an essential production step in life sciences, too.
Kontakt
Dr. Gabriele Spoerl;     Tel.: [+49 351 4081 604];     Email: gabriele.spoerl@ilkdresden.de; CryoWorkshop2016@ilkdresden.de
Themen
Cell/tissue cryopreservation and storage challenges: advanced devices for cryopreservation and freeze-drying, cryobanking of biologicals, 3D-scaffolds / tissue engineering for medical and diagnostic applications, strategies with alternative cryoprotectants for tissues cryopreservation, industrial solutions in biomaterial processing. Freezing and storage of active agents for in-vitro and in-vivo applications: damage processes on active agents caused by cold application, process limitations and impact factors on product stability, process validation – analytics, monitoring and simulation of process and product loss, vitrification of cellular products without cryoprotectants, industrial freezing solutions - large scale and multi-product plant.
Verwandte Fachgebiete
98.
 
MUCOVAD 2016 — Mucosal Vaccines, Adjuvants & Delivery
ID
762199
Termin
14. Sep 2016 - 16. Sep 2016
Ort
Lausanne, Schweiz
Zusammenfassung
MUCOVAD 2016 will be an opportunity for researchers to hear updates on new developments in the area of mucosal vaccines and associated adjuvantation and delivery mechanisms/platforms
99.
 
Chemical biology approaches to assessing and modulating mitochondria
ID
776909
Termin
26. Sep 2016 - 27. Sep 2016
Ort
The Royal Society at Chicheley Hall, Buckinghamshi, Großbritannien
Zusammenfassung
Mitochondria are central to many current biomedical problems. In these, variations in chemical processes are critical, but progress in understanding these and in developing therapies has been hampered by lack of methods to measure and manipulate mitochondrial 'chemistry'. This meeting will explore the interface of chemical biology and mitochondrial studies to open up new avenues for research and therapeutic interventions.
Kontakt
Naomi Asantewa-Sechereh;     Tel.: [+442074512515];     Email: kavli.events@royalsociety.org
Themen
redox signalling, Reactive oxygen species (ROS), oxidative damage, mitochondria, mitochondrial therapies
Verwandte Fachgebiete
100.
 
14th Annual Pharma IT Congress
ID
787536
Termin
28. Sep 2016 - 29. Sep 2016
Ort
London, Großbritannien
Zusammenfassung
Oxford Global are proud to present the 14th Annual Pharmaceutical IT Congress, taking place on 28 – 29 September 2016 in London, UK. This highly established event will focus on exciting Big Data implementation case studies, novel research results in translational informatics, updates in data management for Real-World Evidence and novel IT solutions. The pharmaceutical IT industry represents a complex area of research that is under continuous pressure to develop novel solutions to improve its performance. Thanks to recent advancements in cloud computing solutions, Real-World Data and analytics, the industry is flourishing.
Kontakt
Guillaume Alonso;     Tel.: [+44 (0)1865 248 455];     Email: g.alonso@oxfordglobal.co.uk
Themen
Over 200 delegates representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic institutions Over 40 presentations and case studies focusing on the key developments in Big Data, Translational Informatics, Data Management for Real-World Evidence and IT Solutions Including 4 interactive streams: - Utilising Big Data In R&D - Translational Informatics - Data Management For Real-World Evidence - Novel IT Solutions
Verwandte Fachgebiete
101.
 
ICONAN 2016 — International Conference On Nanomedicine And Nanobiotechnology
ID
785123
Termin
28. Sep 2016 - 30. Sep 2016
Ort
Paris, Frankreich
Zusammenfassung
The target is to set up one of the most attractive international annual gatherings of experts from all around the world, in order for them to exchange about their latest research results and share their ideas.
Kontakt
ICONAN 2016 Organizing Committee;     Tel.: [0033781201182];     Email: iconan2016@premc.org
Themen
Targeted drug delivery and nanocarriers, Nanomedicine for cancer diagnosis & therapy, Biological & medical nanodevices and biosensors, Tissue engineering and regenerative nanomedicine, Toxicology and risk assessment of nanomedicine systems, Nano-Imaging for diagnosis, therapy and delivery, Bionanocatalysis and nanobisystems, Microfluidics in nanomedicine and nanobiology.
Verwandte Fachgebiete
102.
 
The Structure of Clinical Trials and Experimental Therapeutics - University of Oxford
ID
749593
Termin
10. Okt 2016 - 14. Okt 2016
Ort
Oxford, Großbritannien
Kontakt
Course Administrator;     Tel.: [01865 286955];     Email: expther@conted.ox.ac.uk
Themen
pharmacology, drug development, clinical trials, experimental therapeutics, oxford
103.
 
GCC Pharma Congress
ID
773534
Termin
17. Okt 2016 - 20. Okt 2016
Ort
Dubai, Vereinigte Arabische Emirate
Zusammenfassung
As the GCC countries healthcare moves towards a more patient-centric model, pharmacists are playing an increasingly important role in providing quality care to patients and they are vital members of the healthcare team. Pharmacists play an important role as leaders to improve healthcare outcomes, decrease cost, reduce patient safety risk, optimise medication management systems and align the pharmacy services with the management strategies that measure and reward quality performance. However, the continuing evolution of pharmacist role is tied to numerous challenges including collaboration with the different stakeholders in the medical community, learning about new technologies, remaining competitive in the marketplace, improving patient outcomes, maintaining productivity and more.
104.
 
APAMT2016 — Asia Pacific Association of Medical Toxicology 15th Scientific Congress
ID
788259
Termin
17. Nov 2016 - 20. Nov 2016
Ort
Singapore, Singapur
Zusammenfassung
The Toxicology Society of Singapore warmly invites all of you to join us in the 15th International Scientific Conference of the Asia Pacific Medical Association of Medical Toxicology (APAMT) 2016. This will be the first time that the APAMT conference is held in Singapore. APAMT 2016 promises an exciting experience as we bring together Clinical Toxicologists, Specialists in Poisons Information and researchers and scientists from all over the world, especially from the Asia Pacific to discuss their research, share experience and make new friends. The theme for this conference is “A Toxicologist’s Rendezvous – Meeting of the Disciplines”.

We look forward to welcoming you in Singapore in 2016!

Kontakt
Conference Secretariat;     Tel.: [+65 6570 6280];     Email: info@apamt2016.com
Themen
Toxicology Poison Analysis Chemical Environmental Toxinology
105.
 
28th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
ID
773695
Termin
28. Nov 2016 - 02. Dez 2016
Ort
München, Deutschland
Zusammenfassung
It is our great pleasure to announce that the   28th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics   will take place in Munich.  Hosted by the European Organisation for Research and Treatment of Cancer (EORTC), the National Cancer Institute (NCI) and the American Association for Cancer Research (AACR), the 2016 Symposium will bring together around 2000 academics, scientists and pharmaceutical industry representatives from across the globe to discuss innovations in drug development, target selection and the impact of new discoveries in molecular biology. As a one-of-a-kind Symposium at the forefront of drug development, it will enable participants to apply the latest findings and knowledge in their work and practice. This edition will also build on the success of the previous symposium which was widely praised for the quality of its programme, inspirational contributions and exclusive insights.
Verwandte Fachgebiete
106.
 
6th Munich Biomarker Conference - Clinical Practice and Targeted Therapies in Personalized Medicine
ID
789581
Termin
29. Nov 2016 - 30. Nov 2016
Ort
München, Deutschland
Zusammenfassung
We believe that the challenges of future medicine can only be solved by an interdisciplinary approach. On the one hand, biomarker-driven drug development follows common strategies, on the other hand, only joint efforts will transform the health care system. Therefore, the 6th Munich Biomarker Conference is open to various indications, including, but not limited to, oncology, respiratory diseases, immunology and infection, neurological disorders and orphan diseases.
Kontakt
BioM Biotech Cluster Development GmbH;     Tel.: [+49 (0) 89 / 89 96 79-0];     Email: info@bio-m.org
Themen
Biomarker discovery, validation and clinical use, biomarkers in drug discovery and development, innovative biomarker, technologies, cell-based and cell-free assays, liquid biopsy, biomarkers for immunotherapy, personalized medicine, companion diagnostics and patient selection, combination therapies, patient monitoring, evidence-based medicine
107.
 
Antibodies & Complement: Effector Functions, Therapies & Technologies
ID
781835
Termin
20. Jun 2017 - 23. Jun 2017
Ort
Albufeira, Portugal
Zusammenfassung
The antibody response and the complement system are major effector arms of the immune system. Both have been involved in a plethora of pathological conditions – including autoimmunity, allergy, infections and cancer- and regulate, mainly through their receptors (FcR and CR respectively) cell activation, migration, survival but also metabolism. As the portfolio of antibody- and complement-effector function grow, high-end technological solutions are developed and novel therapeutic applications are proposed.

This Zing conference will focus attention on key advances in both fields with the aim at fostering discussions between antibody experts and complement experts.

Verwandte Fachgebiete
LYOPHILIZATION USA
PAIN THERAPEUTICS
RNA Therapeutics
Superbugs & Superdrugs - Pushing financial incentives and collaborative incentives to accelerate clinical success
Pre-Filled Syringes East Coast

Interessant...

You can advertise your event or services in this space.

Stand vom 30. Oktober 2092